Sabra Health Care [SBRA] vs Ventas [VTR] Detailed Stock Comparison

Sabra Health Care

NASDAQ

Ventas

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sabra Health Care wins in 15 metrics, Ventas wins in 5 metrics, with 0 ties. Sabra Health Care appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Sabra Health Care	Ventas	Better
P/E Ratio (TTM)	24.29	194.30	Sabra Health Care
Price-to-Book Ratio	1.63	2.52	Sabra Health Care
Debt-to-Equity Ratio	91.74	108.90	Sabra Health Care
PEG Ratio	0.13	400.75	Sabra Health Care
EV/EBITDA	15.48	21.81	Sabra Health Care
Profit Margin (TTM)	24.84%	2.82%	Sabra Health Care
Operating Margin (TTM)	38.43%	14.15%	Sabra Health Care
EBITDA Margin (TTM)	38.43%	14.15%	Sabra Health Care
Return on Equity	6.66%	1.38%	Sabra Health Care
Return on Assets (TTM)	3.20%	1.92%	Sabra Health Care
Free Cash Flow (TTM)	$310.54M	$725.78M	Ventas
Dividend Yield	6.57%	2.92%	Sabra Health Care
1-Year Return	17.98%	16.01%	Sabra Health Care
Price-to-Sales Ratio (TTM)	6.03	5.72	Ventas
Enterprise Value	$6.81B	$42.06B	Ventas
EV/Revenue Ratio	9.28	8.32	Ventas
Gross Profit Margin (TTM)	67.70%	42.15%	Sabra Health Care
Revenue per Share (TTM)	$3	$12	Ventas
Earnings per Share (Diluted)	$0.76	$0.33	Sabra Health Care
Beta (Stock Volatility)	0.82	0.97	Sabra Health Care

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Sabra Health Care vs Ventas Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Sabra Health Care	0.82%	6.34%	8.28%	13.54%	23.47%	15.07%
Ventas	-0.09%	2.35%	4.03%	8.65%	4.60%	19.25%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Sabra Health Care	17.98%	27.24%	30.37%	-20.76%	-23.69%	0.62%
Ventas	16.01%	43.11%	61.80%	21.93%	19.56%	99.31%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Sabra Health Care (SBRA): View Full Stock Overview

Ventas (VTR): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Sabra Health Care vs Ventas

Metric	SBRA	VTR
Market Information
Market Cap i	$4.43B	$28.94B
Market Cap Category	Mid cap	Large cap
10 Day Avg. Volume i	3,029,470	2,946,590
90 Day Avg. Volume i	2,589,517	2,823,467
Last Close	$19.62	$69.12
52 Week Range	$15.60 - $20.03	$56.68 - $71.36
% from 52W High	-2.05%	-3.14%
All-Time High	$72.39 (Apr 22, 2002)	$96.05 (May 20, 2013)
% from All-Time High	-72.90%	-28.04%
Growth Metrics
Quarterly Revenue Growth	0.08%	0.14%
Quarterly Earnings Growth	1.73%	0.13%
Financial Health
Profit Margin (TTM) i	0.25%	0.03%
Operating Margin (TTM) i	0.38%	0.14%
Return on Equity (TTM) i	0.07%	0.01%
Debt to Equity (MRQ) i	91.74	108.90
Cash & Liquidity
Book Value per Share (MRQ)	$11.31	$25.43
Cash per Share (MRQ)	$0.42	$0.40
Operating Cash Flow (TTM) i	$338.84M	$1.38B
Levered Free Cash Flow (TTM) i	$286.91M	$869.68M
Dividends
Last 12-Month Dividend Yield i	6.57%	2.92%
Last 12-Month Dividend i	$1.20	$1.83

Valuation & Enterprise Metrics Analysis: Sabra Health Care vs Ventas

Metric	SBRA	VTR
Price Ratios
P/E Ratio (TTM) i	24.29	194.30
Forward P/E i	27.15	400.75
PEG Ratio i	0.13	400.75
Price to Sales (TTM) i	6.03	5.72
Price to Book (MRQ) i	1.63	2.52
Market Capitalization
Market Capitalization i	$4.43B	$28.94B
Enterprise Value i	$6.81B	$42.06B
Enterprise Value Metrics
Enterprise to Revenue i	9.28	8.32
Enterprise to EBITDA i	15.48	21.81
Risk & Other Metrics
Beta i	0.82	0.97
Book Value per Share (MRQ) i	$11.31	$25.43

Financial Statements Comparison: Sabra Health Care vs Ventas

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SBRA	VTR
Revenue/Sales i	$183.54M	$1.36B
Cost of Goods Sold i	$59.93M	$785.71M
Gross Profit i	$123.61M	$572.37M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	$67.39M	$197.69M
EBITDA i	$111.31M	$521.86M
Pre-Tax Income i	$40.72M	$37.80M
Income Tax i	$413,000	$-10.56M
Net Income (Profit) i	$40.30M	$48.36M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SBRA	VTR
Cash & Equivalents i	$22.65M	$897.85M
Total Current Assets i	$155.28M	$1.35B
Total Current Liabilities i	$112.07M	$1.30B
Long-Term Debt i	$2.42B	$13.73B
Total Shareholders Equity i	$2.70B	$10.83B
Retained Earnings i	$-1.91B	N/A
Property, Plant & Equipment i	N/A	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SBRA	VTR
Operating Cash Flow i	$82.99M	$352.04M
Capital Expenditures i	N/A	N/A
Free Cash Flow i	$80.26M	$203.39M
Debt Repayment i	$-24.40M	$-88.55M
Common Stock Repurchase i	$-5.39M	N/A

Short Interest & Institutional Ownership Analysis

Metric	SBRA	VTR
Shares Short i	19.22M	13.72M
Short Ratio i	8.24	4.13
Short % of Float i	0.11%	0.04%
Average Daily Volume (10 Day) i	3,029,470	2,946,590
Average Daily Volume (90 Day) i	2,589,517	2,823,467
Shares Outstanding i	237.59M	437.08M
Float Shares i	235.92M	448.90M
% Held by Insiders i	0.01%	0.01%
% Held by Institutions i	1.01%	1.00%

Dividend Analysis & Yield Comparison: Sabra Health Care vs Ventas

Metric	SBRA	VTR
Last 12-Month Dividend i	$1.20	$1.83
Last 12-Month Dividend Yield i	6.57%	2.92%
3-Year Avg Annual Dividend i	$1.20	$1.66
3-Year Avg Dividend Yield i	2.11%	0.91%
3-Year Total Dividends i	$3.60	$4.98
Ex-Dividend Date	May 16, 2025	Mar 31, 2025

Sabra Health Care [SBRA] vs Ventas [VTR] Detailed Stock Comparison